Blueprint Medicines (NASDAQ:BPMC) Stock Rating Lowered by StockNews.com
StockNews.com lowered shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) from a hold rating to a sell rating in a research report released on Friday. A number of other research firms have also issued reports on BPMC. Guggenheim reissued a “buy” rating on shares of Blueprint Medicines in a report on Wednesday, December 11th. JPMorgan […]
StockNews.com lowered shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) from a hold rating to a sell rating in a research report released on Friday. A number of other research firms have also issued reports on BPMC. Guggenheim reissued a “buy” rating on shares of Blueprint Medicines in a report on Wednesday, December 11th. JPMorgan […]
